Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More | Frank Vinluan | 09/25/20 | National |
F2G Lands $60M for a New Tack on Taking Out Rare Fungal Infections | Frank Vinluan | 08/12/20 | Europe |
Vesigen Nabs $28M to Wrap “ARMMS” Around Large Molecule Drug Delivery | Frank Vinluan | 07/22/20 | Boston |
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer’s | Frank Vinluan | 07/01/20 | Boston |
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases | Frank Vinluan | 10/31/19 | Boston |
Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus | Bernadette Tansey | 09/26/19 | San Francisco |
InCarda Breathes In $42M for Clinical Tests of Inhalable Heart Drug | Frank Vinluan | 11/08/18 | San Francisco |
Boston Tech Watch: Nuance, Relayr, Markforged, Grapevine & More | Jeff Bauter Engel | 09/07/18 | Boston |
First Clinical Trial Done, Elysium Lands $20M for Health Supplements | Frank Vinluan | 12/06/16 | New York |
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding | Angela Shah | 04/30/15 | Texas |
Texas Roundup: DNAtrix, Nanolinea, Wireless Seismic, Illumitex, TMCx | Angela Shah | 10/20/14 | Texas |
West Coast Biotech Roundup: Illumina, Atara, Invitae, Canaan & More | Alex Lash | 10/17/14 | San Francisco |
Indel Grabs $1.4M for Antibiotics | Luke Timmerman | 04/28/11 | Seattle |
Longwood Raises First Fund, Biogen Adds Executives, Boston Scientific Acquires Intellect, & More Boston-Area Life Sciences News | Erin Kutz | 01/07/11 | Boston |
SCVNGR Scares Up $15M, Genocea Gets $35M, Zeo Zeros in on $12.3M, & More Boston-Area Deals News | Rebecca Zacks | 01/05/11 | Boston |
Genocea Biosciences Raises $35M from J&J and Others for Vaccines Business | Ryan McBride | 01/03/11 | Boston |
Alnylam’s Spinoff Strategy, Genzyme’s Gaucher-Business Future, Adimab’s Antibody Ambitions, & More Boston-Area Life Sciences News | Rebecca Zacks | 02/25/09 | Boston |
Vertex’s $320M SPO, Verenium and BP’s Joint Venture, Genocea’s $23M Series A, & More Boston-Area Deals News | Rebecca Zacks | 02/20/09 | Boston |
Genocea Biosciences Closes $23M Series A, Adds New CEO Bakali | Ryan McBride | 02/19/09 | Boston |